Are We About to Make Bone Density Sexy?

Read on Substack

Everyone's optimizing their brain. Nobody's talking about their bones.

Your Bones Called. They're Being Ignored.

The DEXA scan is having a moment.

If you don’t know what a DEXA scan is — it’s basically an x-ray that tells you how strong your bones actually are, and makes you viscerally aware that you are, in fact, a person made of skeleton. Everyone’s booking one. Good. We love a woman who knows her numbers.

But here’s the problem with the DEXA boom: we’ve built a culture of knowing without a culture of doing.

You get your scan. You see the numbers. Maybe they’re fine, maybe they’re not. And then your doctor says the same thing doctors have been saying for decades: take calcium. Take vitamin D. Do some weight-bearing exercise.

That’s it. That’s the standard of care. In 2026.

Meanwhile, everyone has a CoQ10 on their counter. AG1 just dropped an entire new line covering sleep, immune health, and cognitive function. The longevity girlies are cycling creatine, collagen, and lion’s mane before 9am. We are out here optimizing our brains, our guts, our mitochondria…and completely ignoring the literal scaffolding holding all of it up.

Someone please tell me why bones aren’t sexy yet.Because the market thinks they’re about to be. One in two women over 50 will break a bone in their lifetime. Women can lose up to 20% of their bone density in the years following menopause. And then GLP-1s showed up and made this everyone’s problem, not just their mom’s.

Here’s the part of the Ozempic conversation nobody is having loudly enough: GLP-1 associated weight loss accelerates bone loss. Muscle loss reduces the mechanical load on bone. Suddenly you have millions of younger, health-engaged, actively-spending women losing bone density as a side effect of the biggest wellness trend of the decade — and most of them have absolutely no idea.

The DEXA boom told us we have a problem. GLP-1s made that problem younger, bigger, and more urgent.

So here’s what I keep thinking about: menopause got a rebrand. Gut health got a rebrand. The supplement industry figured out how to make magnesium feel like a personality trait. And bone density is just... sitting here. Unglamorous. Untouched. Waiting.

There’s a $30 billion market, a brand new at-risk consumer who didn’t exist two years ago, and a supplement shelf that looks exactly the same as it did in 2003.

The category is about to break open. I have thoughts on who’s going to win — and more importantly, what’s completely missing.

So what’s actually out there?

Let’s do a quick tour of the landscape, because it tells you everything about the white space.

Osteoboost is the most clinically interesting thing to happen in this category in years. It’s a wearable belt that received FDA clearance for low bone density, has real clinical data behind it, and made TIME’s Best Inventions list. Also $995, prescription only, and looks like a medical device because it is one. It’s building the clinical infrastructure. Nobody is building the consumer brand.

Then there are weighted vests, which are all over your For You page right now, being marketed as the bone density solution every wellness fiend needs. Except the data is...not quite there yet. And beyond the data question, are we really out here schlepping a 10-pound vest around town? Maybe. Maybe we make walking around with what is essentially a tiny sandbag situation sexy? The internet definitely wants this to be the answer.

And then there’s the supplement shelf. Thorne. Solgar. Pure Encapsulations. Good products. Genuinely. But calcium + vitamin D + K2 in a brown glass bottle with a clinical label is not capturing the woman who just got her DEXA results and is lying in bed at 11pm opening her notes app. She’s not going to Thorne’s website. She’s going wherever the thing feels like it was made for her.

That thing does not exist yet.

The CPG white space is enormous

Think about what happened to magnesium. For decades it sat in the back of the vitamin aisle next to the fish oil. Then someone put it in a pretty bottle, called it a “sleep supplement,” gave it a calming visual identity, and suddenly every wellness woman in America has a magnesium glycinate on her nightstand.

Same thing happened to gut health. Greens powders. Collagen. Creatine, which is actively having its girlification moment right now.

The formula is not complicated: take a supplement with real science behind it, give it a brand identity that speaks to a specific woman’s specific moment, distribute it where she already shops, and let the content engine do the rest.

Bone density has the science. It has the urgency. It has a growing, newly-aware consumer base who just got their DEXA results and are actively looking for something to take. It does not yet have its Arrae. It does not have its Nécessaire. It doesn’t have its anything.

The investor POV

The categories that explode in wellness follow a pattern: clinical awareness builds first, then a cultural moment cracks it open for the consumer, then one brand shows up with the right identity at the right time and owns it.

We are sitting at the cultural moment for bone health right now. DEXA culture built the awareness. The menopause conversation made women under 50 pay attention. GLP-1s created a new at-risk consumer overnight. The infrastructure exists, the science is there, the clinical validation is there, the physician interest is there.

What’s missing is the brand that makes a 35-year-old woman feel the same way about her bone density that she feels about her gut health. The one that sits on her shelf and makes her feel like she’s ahead of it, not behind it.

That brand is going to be built. The question is just who builds it first.

All the best,

Rachel & WGV Team